Mangalam Drugs (India) Probability of Future Stock Price Finishing Under 105.78
| MANGALAM | 122.13 15.45 14.48% |
Mangalam |
Mangalam Drugs Target Price Odds to finish below 105.78
The tendency of Mangalam Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 105.78 or more in 90 days |
| 122.13 | 90 days | 105.78 | about 9.54 |
Based on a normal probability distribution, the odds of Mangalam Drugs to drop to 105.78 or more in 90 days from now is about 9.54 (This Mangalam Drugs And probability density function shows the probability of Mangalam Stock to fall within a particular range of prices over 90 days) . Probability of Mangalam Drugs And price to stay between 105.78 and its current price of 122.13 at the end of the 90-day period is about 51.82 .
Assuming the 90 days trading horizon Mangalam Drugs has a beta of 0.32. This indicates as returns on the market go up, Mangalam Drugs average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Mangalam Drugs And will be expected to be much smaller as well. Additionally Mangalam Drugs And has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Mangalam Drugs Price Density |
| Price |
Predictive Modules for Mangalam Drugs
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mangalam Drugs And. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Mangalam Drugs Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Mangalam Drugs is not an exception. The market had few large corrections towards the Mangalam Drugs' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Mangalam Drugs And, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Mangalam Drugs within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.13 | |
β | Beta against Dow Jones | 0.32 | |
σ | Overall volatility | 10.25 | |
Ir | Information ratio | -0.08 |
Mangalam Drugs Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mangalam Drugs for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mangalam Drugs And can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Mangalam Drugs And generated a negative expected return over the last 90 days | |
| The company reported the revenue of 3.67 B. Net Loss for the year was (90.72 M) with profit before overhead, payroll, taxes, and interest of 1.17 B. | |
| About 55.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Additional Considerations Required While Assessing Mangalam Drugs Organics Strong Earnings - Simply Wall St |
Mangalam Drugs Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Mangalam Stock often depends not only on the future outlook of the current and potential Mangalam Drugs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mangalam Drugs' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.8 M | |
| Cash And Short Term Investments | 11.9 M |
Mangalam Drugs Technical Analysis
Mangalam Drugs' future price can be derived by breaking down and analyzing its technical indicators over time. Mangalam Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Mangalam Drugs And. In general, you should focus on analyzing Mangalam Stock price patterns and their correlations with different microeconomic environments and drivers.
Mangalam Drugs Predictive Forecast Models
Mangalam Drugs' time-series forecasting models is one of many Mangalam Drugs' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Mangalam Drugs' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Mangalam Drugs And
Checking the ongoing alerts about Mangalam Drugs for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Mangalam Drugs And help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Mangalam Drugs And generated a negative expected return over the last 90 days | |
| The company reported the revenue of 3.67 B. Net Loss for the year was (90.72 M) with profit before overhead, payroll, taxes, and interest of 1.17 B. | |
| About 55.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Additional Considerations Required While Assessing Mangalam Drugs Organics Strong Earnings - Simply Wall St |
Other Information on Investing in Mangalam Stock
Mangalam Drugs financial ratios help investors to determine whether Mangalam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mangalam with respect to the benefits of owning Mangalam Drugs security.